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Background:  Few  studies  have  assessed  the  temporal  association  between  homelessness  and  injection
drug  use,  and  injection-related  risk  behavior.
Methods: Among  a cohort  of  1405  current  and  former  injection  drug  users  in  follow-up  from  2005  to
2009,  we used  random  intercept  models  to assess  the temporal  association  between  homelessness  and
subsequent  injection  drug use,  and  to  determine  whether  the  association  between  homelessness  and
sustained  injection  drug  use  among  active  injectors  differed  from  the association  between  homelessness
and  relapse  among  those  who  stopped  injecting.  We  also assessed  the  association  between  homelessness
and  subsequent  injection-related  risk  behavior  among  participants  who  injected drugs  consecutively
across  two visits.  Homelessness  was  categorized  by  duration:  none,  <1  month,  and  ≥1  month.
Results: Homelessness  was  reported  on at least  one  occasion  by  532  (38%)  participants.  The  relationship
between  homelessness  and  subsequent  injection  drug  use  was different  for  active  injectors  and  those
who  stopped  injecting.  Among  those  who  stopped  injecting,  homelessness  was  associated  with relapse
[<1  month:  AOR  = 1.67,  95% CI  (1.01,  2.74);  ≥1  month:  AOR  =  1.34  95%  CI (0.77, 2.33)].  Among  active  injec-
tors,  homelessness  was  not  associated  with  sustained  injection  drug  use  [<1 month:  AOR  = 1.03,  95%  CI
(0.71,  1.49);  ≥1  month:  AOR  = 0.81  95% CI (0.56,  1.17)].  Among  those  injecting  drugs  across  two  con-
secutive  visits,  homelessness  ≥1  month  was  associated  with  subsequent  injection-related  risk  behavior
[AOR  = 1.61,  95%  CI  (1.06,  2.45)].
Conclusion: Homelessness  appears  to  be  associated  with  relapse  and  injection-related  risk  behavior.
Strengthening  policies  and  interventions  that  prevent  homelessness  may  reduce  injection  drug  use  and
injection-related  risk  behaviors.. Introduction
Injection drug use remains a signiﬁcant public health issue, as a
isk factor for premature mortality, HIV, and hepatitis C virus (HCV)
nfection (Armstrong et al., 2006; The Centers for Disease Control
nd Prevention, 2009; Mehta et al., 2011; Vlahov et al., 2008). Injec-
ion drug use also poses a considerable burden on society due to
he costs of drug-related crime, loss of productivity (Alexandre
nd French, 2004), and other negative social implications (Wood
t al., 2001). Approximately 1 million persons in the United States
re estimated to have injected drugs, with the highest prevalence
eported in Fresno, California, and Baltimore, Maryland (Brady et al.,
∗ Corresponding author at: Johns Hopkins University, Bloomberg School of Public
ealth,  624 N. Broadway Street, Room 895, Baltimore, MD 21205, USA.
el.: +1 443 287 8271; fax: +1 410 955 9088.
E-mail address: slinton@jhsph.edu (S.L. Linton).
376-8716     © 2013 Elsevier Ireland Ltd. 
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Open access under CC BY-NC-ND license.© 2013 Elsevier Ireland Ltd. 
2008). According to recent estimates, Baltimore ranked ﬁrst in the
country in per capita prevalence of injection drug use, with an esti-
mated 336 injection drug users (IDUs) per 10,000 population aged
15–64 reported (Brady et al., 2008).
Homelessness has consistently been associated with injection
drug use (Aidala et al., 2005; Bourgois, 1998; Briggs et al., 2009;
Roy et al., 2010; Song et al., 2000) and a number of factors asso-
ciated with homelessness, including poverty (Mizuno et al., 2009),
inequitable housing policies (Dickson-Gomez et al., 2007), incarcer-
ation (Mizuno et al., 2009), social networks (Davey-Rothwell et al.,
2011), and poor mental health (Aidala et al., 2005) have also been
associated with injection drug use (Bohnert et al., 2009; Genberg
et al., 2011a; Mackesy-Amiti et al., 2012; Mehta et al., 2012).
However, while injection drug use and homelessness commonly
Open access under CC BY-NC-ND license.co-occur, few studies have characterized the temporal relationship
between homelessness and injection drug use (Aidala et al., 2005;
Mehta et al., 2012; Shah et al., 2006). It is also unclear whether
homelessness can trigger relapse into injection drug use among
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hose who have stopped injecting, and increased risk behavior
mong those actively injecting.
There  is some evidence to suggest a temporal link between
omelessness and injection drug use. In prior studies, homeless-
ess has been associated with initiation of injection drug use (Crofts
t al., 1996; Roy et al., 2010) and has been negatively associated
ith utilization of mental health care and drug treatment (Appel
t al., 2004; Muir-Cochrane et al., 2006), factors which tend to be
ssociated with reduced drug use (The Substance Abuse and Mental
ealth Services Administration, 2005). Homelessness has also been
ound to mediate the relationship between adverse life events,
uch as childhood abuse and incarceration, and drug use (Chen
t al., 2004; Krishnan et al., 2012). Additionally, drug use has been
eported to be a coping strategy for untreated mental illness and
ncomfortable living conditions experienced during homelessness
Williams and Stickley, 2011; Wright et al., 2005).
A temporal link between homelessness and injection-related
isk behaviors has also been suggested (Aidala et al., 2005; Bourgois,
998; Briggs et al., 2009; Small et al., 2006; Werb et al., 2008).
ailure to cook or ﬁlter drugs, and unsafe disposal of drug parapher-
alia has been reported to occur among homeless persons who  rush
njection to prevent conﬁscation and arrest by police (Small et al.,
006; Werb et al., 2008). Additionally, paraphernalia sharing, which
as been associated with transmission of blood borne diseases (The
enters for Disease Control and Prevention, 2001; Sulkowski et al.,
002), has been reported as a consequence of conﬁscation of ster-
le syringes by police (Werb et al., 2008) and lack of income among
omeless persons (Bourgois, 1998).
Despite the extensive literature supporting a link between
omelessness, injection drug use, and injection-related risk behav-
or, gaps remain. The temporality of these relationships has not
een assessed in a number of prior studies. Further, we  and oth-
rs have demonstrated that IDUs exhibit complex patterns of drug
njection throughout their lifetime (Genberg et al., 2011b) and fre-
uently transition in and out of injection drug use (Galai et al.,
003). Homelessness may  be an important trigger for relapse
mong those who have stopped injecting, and for injection-related
isk behavior among those who are persistent injectors. Prior stud-
es have also not distinguished between those homeless for shorter
s. longer periods of time, which may  differently impact risk.
The  objectives of this study were: (1) to assess the temporal
elationship between homelessness and injection drug use among
urrent and former IDUs, (2) to assess whether homelessness differ-
ntly impacts sustained injection drug use among active injectors
s. relapse among those who have stopped injecting; and (3)
o assess the temporal relationship between homelessness and
njection-related risk behavior among persistent injectors.
.  Methods
.1. Ethics statement
All  participants provided informed consent. The study was
pproved by the Johns Hopkins Bloomberg School of Public Health
nstitutional Review Board.
.2. Study sample
The  rationale and methods of the AIDS Linked to the Intra-
enous Experience (ALIVE) have been described (Vlahov et al.,
991). Brieﬂy, a community-based sample of 2921 current and
ormer IDUs in Baltimore was recruited between 1988 and 1989
hrough street outreach. Participants were eligible to participate
n the initial recruitment period if they were 18 years of age or
lder and reported injection drug use within the past 11 years.pendence 132 (2013) 457– 465
Additionally,  HIV positive participants had to be AIDS-free at
enrollment to be eligible. To account for deaths and losses to
follow-up, a total of 1510 participants were enrolled across four
additional phases of recruitment (1994–1995, 1998, 2000, and
2005–2008); eligibility criteria were similar across waves. In the
ALIVE cohort, mortality has ranged from 3 to 5% per year and loss
to follow-up has ranged from 5 to 7% per year among surviving
participants.
For this analysis, we included participants from all recruitment
waves that attended at least two  study visits after 2005 (n = 1422),
when the study questionnaire was  modiﬁed to include additional
questions on homelessness. These participants contributed a total
of 7096 visits. We excluded visits with a gap greater than 2 years
relative to the previous visit (n = 48), and visits missing data on
covariates of interest (n = 388). The ﬁnal study sample included
1405 participants who contributed 6660 visits. The median num-
ber of visits per person was 4 (IQR: 3–6 visits), and the median time
between visits was  183 days (IQR: 181–192 days).
2.3. Data collection
Follow-up visits for ALIVE occur semi-annually. At each visit,
participants complete surveys and laboratory testing. Clinical infor-
mation is ascertained by trained interviewers. Information on
behavior, life events, and health-related outcomes is captured using
audio-computer assisted self-interview (ACASI; Macalino et al.,
2002).
The primary outcome for this analysis was  injection drug use,
deﬁned as self-reported injection of heroin, cocaine, speedball,
and/or any other drug not prescribed by a health care provider
within the last 6 months. Injection drug use was  treated as dichoto-
mous, with no reported injection as the reference category. A
secondary outcome was  injection-related risk behavior, deﬁned
as report of at least one of the following in the past 6 months:
needle sharing, cotton sharing, and shooting gallery attendance.
The primary exposure was homelessness, deﬁned as self-reported
homelessness, or residence in a shelter, park, abandoned building,
bus/train station, or on the street, for at least one night in the past 6
months. Duration of homelessness is captured as a categorical vari-
able: <1 week, ≥1 week but <1 month, ≥1 month but <6 months, and
≥6 months. The association between homelessness and injection
drug use was similar in the ﬁrst two categories and in the latter two
categories. Accordingly, homelessness was categorized into three
categories for analysis: none, <1 month, and ≥1 month.
Covariates were selected a priori based upon prior studies that
have identiﬁed correlates of homelessness, injection drug use, and
injection-related risk behavior (Aidala et al., 2005; Celentano et al.,
1991; Galai et al., 2003; Genberg et al., 2011a; Golub et al., 2007;
Latkin et al., 1995; Mehta et al., 2012; Milloy et al., 2008; Shah
et al., 2006; Tobin et al., 2010). Covariates were dichotomized as
yes or no, unless otherwise stated. The following covariates were
ﬁxed at the ﬁrst visit: gender, race (black vs. non-black), and age
(categories: <35, 35–54, ≥55). Covariates treated as time-varying
included: HIV status (positive vs. negative), current employment,
depressive symptoms in the last week (CES-D (Radloff, 1977) cut-
off score of 23), and self-reported diagnoses or treatment by a
health care provider, for depression, manic depression, anxiety, or
schizophrenia. Additional time-varying factors measured in the last
6 months included: suicidal ideation, legal income ($5000 USD  vs.
less), incarceration (≥1 week vs. less), frequency of injection (dailyattendance, methadone maintenance, detoxiﬁcation, trading sex
for money, drugs, shelter or food, and sex with an IDU partner. Last,
prior history of homelessness, deﬁned as having at least one prior
episode of homelessness, was included in analysis.
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.4. Statistical analysis
Characteristics of participants at the ﬁrst visit were compared
cross strata of homelessness at the ﬁrst visit using chi-square
ests for categorical variables and Kruskal–Wallis tests for contin-
ous variables. Logistic regression was used to assess temporal
ssociations between homelessness and injection drug use, and
njection-related risk behavior, at the next visit. Random intercepts
Diggle et al., 2002) were applied to the logistic regression model
o adjust for repeated measures among individuals over time,
nd to condition on individual baseline propensity for subsequent
njection drug use and subsequent injection-related risk behavior.
omelessness and other time-varying covariates were lagged one
isit to ensure temporality between these factors and subsequent
njection drug use, and subsequent injection-related risk behavior
e.g., homelessness and other covariates were measured at time
 − 1 and subsequent injection drug use and subsequent injection-
elated risk behavior were measured at time t).
The unadjusted and adjusted associations between home-
essness and subsequent injection drug use, and subsequent
njection-related risk behavior, were assessed in four models.
odel 1 assessed the association between homelessness and subse-
uent injection drug use among all observations (combined model).
ecause it has been suggested that correlates of relapse and sus-
ained injection drug use may  differ (Galai et al., 2003), we stratiﬁed
he combined model according to whether injection drug use was
eported or not reported at the lagged visit. Model 2 assessed
he association between homelessness and relapse among visits
hen injection drug use was not reported at the lagged visit,
nd Model 3 assessed the association between homelessness and
ustained injection drug use among visits when injection drug
se was reported at the lagged visit. Model 4 assessed the asso-
iation between homelessness and subsequent injection-related
isk behavior when injection drug use was consecutively reported
cross two visits. Fig. 1 illustrates the visits when homelessness,
ubsequent injection drug use, subsequent injection-related risk
ehavior, and covariates were measured in each model.
Akaike’s Information Criteria (AIC) was used to evaluate model
t and establish a more parsimonious model that did not include
ll mental health variables. Model ﬁt and parsimony improved with
eletion of suicidal ideation and mental health conditions, exclud-
ng depressive symptoms as measured by CES-D. CES-D has been
ound to have good psychometric properties among persons with
 history of drug use (Weissman et al., 1977). Additionally it may
erve as a better marker of mental illness than diagnosed mental
llness in this analysis, given the low levels of health care access
n this population. Due to collinearity, frequency of injection, nee-
le and cotton sharing, shooting gallery attendance, and non-fatal
verdose were excluded from Model 1 and Model 2.
Interactions between homelessness and prior injection drug use,
ex with an IDU partner and depressive symptoms were explored
y including interaction terms in the combined adjusted model.
ssessment of these interactions was based on literature sup-
orting an association between injection drug use and having a
rug using partner (Latkin et al., 1999), and poor mental health
Mackesy-Amiti et al., 2012). All analyses were performed using
tata (Version 12.1; StataCorp).
.  Results
.1. Study participantsOf  the 1405 participants, the majority were male (66%), black
87%), and between the ages of 35–54 (77%) at the ﬁrst visit.
he distribution of these characteristics was comparable to thependence 132 (2013) 457– 465 459
distribution  in the full ALIVE cohort. At the ﬁrst visit, 347 (25%)
participants reported homelessness. Among these participants,
the duration of homelessness was  reported to be <1 week by 23%
of participants, ≥1 week but <1 month by 23% of participants, ≥1
month but <6 months by 37% of participants and ≥6 months by
18% of participants. The primary location where participants slept
differed by the duration of homelessness at the ﬁrst visit. When
homelessness was  not reported, one’s own home was  the most
frequently reported location (61%), followed by the residence of
a relative (22%) or signiﬁcant other (7%). When homelessness <1
month was  reported, a relative’s residence (27%), shelter (14%), or
one’s own residence (11%) were most frequently reported. When
homelessness ≥1 month was  reported, a shelter (35%), the streets
(18%), or friend’s residence (14%), were most frequently reported.
Characteristics by duration of homelessness at the ﬁrst visit
are shown in Table 1. Homelessness of any duration was com-
mon among those who were younger, non-black, unemployed, and
who reported legal income less than $5000 USD, incarceration,
daily injection, sex with an IDU partner, crack use, trading sex, not
attending methadone maintenance, and attending a detoxiﬁcation
program (p < 0.01 for all). Homelessness was also more common
among those reporting depressive symptoms, suicidal ideation,
and a clinical diagnosis or treatment for a mental health illness
(p < 0.0001 for all). In addition, residential instability, indicated by
the number of moves reported in the last 6 months, injection-
related risk behavior, and non-fatal overdose were higher among
those reporting homelessness (p < 0.0001 for all). Homelessness did
not vary signiﬁcantly by HIV status.
Across follow-up, homelessness was reported on at least one
occasion by 532 (38%) participants, and 267 (50%) of these partici-
pants reported experiencing homelessness more than once.
3.2.  Homelessness and injection drug use
In unadjusted analysis, homelessness of any duration was  sig-
niﬁcantly associated with subsequent injection drug use in the
combined model (Table 2). After adjustment for other covariates
in the combined model, homelessness <1 month and homelessness
≥1 month remained signiﬁcantly associated with subsequent injec-
tion drug use [homelessness <1 month: AOR = 1.74, 95% CI (1.27,
2.40); homelessness ≥1 month AOR = 1.43, 95% CI (1.02, 2.01)].
Other covariates that were signiﬁcantly associated with subse-
quent injection drug use in the adjusted combined model included
younger age, non-black race, male gender, income less than $5000
USD, HIV negative serostatus, depressive symptoms, incarceration,
sex with an IDU partner, and crack use. Past history of homeless-
ness and trading sex were inversely associated with subsequent
injection drug use.
Among  visits when injection drug use was not reported in the
prior 6 months (Table 3), homelessness <1 month was  signiﬁ-
cantly associated with relapse into injection drug use in unadjusted
analysis. The association between homelessness ≥1 month and
relapse was of borderline statistical signiﬁcance in unadjusted
analysis. In adjusted analysis, homelessness <1 month remained
signiﬁcantly associated with relapse [AOR = 1.67, 95% CI (1.01,
2.74)]. Homelessness ≥1 month was also associated with relapse
in adjusted analysis, but the association was not statistically sig-
niﬁcant [AOR = 1.34; 95% CI (0.77, 2.33)]. Depressive symptoms,
incarceration, sex with an IDU partner, and legal income less than
$5000 USD were also signiﬁcantly associated with relapse in the
adjusted model.
Among  visits when injection drug use was reported in the
prior 6 months (Table 4), homelessness <1 month was  signiﬁ-
cantly associated with sustained injection drug use in unadjusted
analysis. Homelessness ≥1 month was not signiﬁcantly associated
with sustained injection drug use in unadjusted analysis. After
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tig. 1. (a) Diagram illustrating when homelessness, injection drug use, and covaria
–3. (b) Diagram illustrating when homelessness, injection-related risk behavior, an
odel  4.
djustment for other covariates, there was no association between
omelessness of any duration and sustained injection drug use
homelessness <1 month: AOR = 1.03, 95% CI (0.71, 1.49); home-
essness ≥1 month: AOR = 0.81 95% CI (0.56, 1.17)]. Male gender,
IV negative serostatus, depressive symptoms, daily injection, and
able 1
haracteristics of participants in the ALIVE study by homelessness strata at the ﬁrst visit 
Total (N = 1405) No Home
(N  = 1058
N % N 
Demographic
Age (years)
19–34 111 7.9 60 
35–54  1087 77.4 830 
55+  207 14.7 168 
Female  481 34.2 372 
Black  1224 87.1 967 
Legal  income ≥$5000 USD 311  22.2 267  
Current  employment 310 22.1 274 
Mean  residential moves 1401 2.3 1054 
Mental  health
Depressive symptoms 357 25.4 200 
Depressiona 341 24.3 221 
Manic  depressiona 169 12.1 104 
Anxietya 172 12.3 103 
Schizophreniaa 175 12.5 109 
Suicidal  thoughts 210 15.0 111 
Suicide  plans 89 6.4 45 
Suicide  attempts 38 2.7 19 
HIV
HIV  positive 400 28.5 309 
Risk  behavior and outcomes
Frequency of injection
None  616 43.8 561 
Less  than daily 333 12.7 232 
Daily  456 32.5 265 
Incarcerated  246 17.5 131 
Sex  with an IDU 399 28.4 243 
Trade  sex for money/drugs 151 10.8 64 
Trade  sex for food/shelter 84 6.0 29 
Crack  use 550 39.2 329 
Methadone  maintenance 316 22.5 263 
Detoxiﬁcation 104 7.4 48 
Needle  sharingb 335 42.5 152 
Cotton  sharingb 314 39.8 150 
Shooting  gallery attendanceb 136 17.2 48 
Needle  exchange program attendanceb 223 28.3 136 
Non-fatal  overdoseb 162 20.5 70 
ote: All factors are measured in the past 6 months, excluding age, gender, race, and c
easured in the past week. Depressive symptoms are measured using the Center for Ep
est performed for all factors excluding residential moves (Kruskal–Wallis test).
a Self-reported diagnosis or treatment for mental health illness by a health care provid
b Among 789 participants reporting injection drug use.e measured longitudinally at the lagged visit (t − 1) and current visit (t) in models
ariates are measured longitudinally at the lagged visit (t − 1) and current visit (t) in
sharing cotton were signiﬁcantly associated with sustained injec-
tion drug use in the adjusted model.
Despite the observed heterogeneity of the impact of home-
lessness on relapse and sustained injection drug use, when an
interaction between injection drug use and homelessness was
(n = 1405).
lessness
)
Homelessness
<1month (N = 158)
Homelessness  ≥1
month  (N = 189)
P-value
% N % N %
5.7 24 15.2 27 14.3 <0.0001
78.5 115 72.8 142 75.1
15.9 19 12.0 20 10.6
35.2 55 34.8 54 28.6 0.210
91.4 121 76.6 136 72.0 <0.0001
25.2 24 15.2 20 10.6 <0.0001
25.9 14 8.9 22 11.6 <0.0001
0.5 158 2.9 189 12.2 <0.0001
18.9 68 43.0 89 47.1 <0.0001
21.0 55 35.0 65 34.4 <0.0001
9.9 38 24.2 27 14.3 <0.0001
9.8 36 22.9 33 17.5 <0.0001
10.3 37 23.4 29 15.3 <0.0001
10.5 51 32.3 48 25.4 <0.0001
4.3 23 14.7 21 11.2 <0.0001
1.8 9 5.7 10 5.3 0.001
29.2 39 24.7 52 27.5 0.477
53.0 23 14.6 32 16.9 <0.0001
21.9 43 27.2 58 30.7
25.1 92 58.2 99 52.4
12.4 58 36.7 57 30.2 <0.0001
23.0 78 49.7 78 41.3 <0.0001
6.1 48 30.4 39 20.6 <0.0001
2.7 28 17.7 27 14.3 <0.0001
31.1 105 66.5 116 61.4 <0.0001
24.9 21 13.3 32 16.9 0.001
4.5 25 15.8 31 16.4 <0.0001
30.6 81 60.0 102 65.0 <0.0001
30.2 76 56.3 88 56.1 <0.0001
9.7 35 25.9 53 33.8 <0.0001
27.5 37 27.4 50 31.9 0.551
14.1 40 29.6 52 33.1 <0.0001
urrent employment measured at the time of the visit, and depressive symptoms
idemiologic Studies Depression Scale (CESD) with a cutoff score ≥23. Chi-squared
er.
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Table  2
Unadjusted and adjusted association between homelessness and subsequent injection drug use among 1405 active and former IDUs contributing 6660 visits from 2005 to
2009  (Model 1).
Unadjusted OR 95%  CI Adjusted ORa 95% CI
Homelessness
No homelessness Ref Ref
<1  Month 2.46 1.79, 3.39 1.74 1.27, 2.40
≥1  Month 2.27 1.62, 3.18 1.43 1.02, 2.01
Past  history of homelessness 0.62 0.47, 0.81 0.76 0.58, 0.98
Demographic
Ages  (years)
19–34 Ref Ref
35–54  0.14 0.07, 0.27 0.38 0.19, 0.77
55+  0.05 0.02, 0.11 0.16 0.08, 0.35
Female  0.67 0.45, 1.00 0.50 0.35, 0.73
Black  0.12 0.06, 0.21 0.34 0.19, 0.62
Legal  income ≥$5000 USD 0.62  0.49, 0.79 0.69 0.54, 0.87
Current  employment 0.73 0.57, 0.93 0.87 0.67, 1.12
Mental  health
Depressive symptoms 2.40 1.90, 3.04 2.01 1.58, 2.54
Depressionb 1.12 0.87, 1.44
Manic  depressionb 1.07 0.78, 1.46
Anxietyb 1.19 0.87, 1.63
Schizophreniab 1.01 0.74, 1.37
Suicidal  thoughts 1.70 1.26, 2.30
Suicide  plans 1.49 0.96, 2.33
Suicide  attempts 2.17 1.04, 4.49
HIV
HIV positive 0.54 0.35, 0.82 0.61 0.41, 0.88
Risk  behavior
Incarcerated 1.83 1.39, 2.42 1.47 1.11, 1.94
Sex  with an IDU 2.02 1.59, 2.57 1.84 1.42, 2.39
Trade  sex for drugs, money, food, or shelter 1.00 0.90, 1.12 0.87 0.76, 0.99
Crack  use 2.32 1.86, 2.90 1.83 1.46, 2.30
Methadone  maintenance 0.82 0.62, 1.07 0.87 0.66, 1.14
Detoxiﬁcation  1.25 0.88, 1.77 1.03 0.72, 1.46
Note: All factors are time-varying excluding age, gender, and race, which are measured at the ﬁrst visit. All time-varying factors are measured within the last 6 months,
excluding current employment measured at the time of the visit, depressive symptoms measured in the past week. Time-varying factors are lagged one visit from when
injection drug use is measured. Past homelessness is deﬁned as any episode of homelessness prior to when homelessness is measured.
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ncluded in the combined model it was not statistically sig-
iﬁcant [homelessness <1 month: (p = 0.255); homelessness ≥1
onth: (p = 0.279)]. Further, no statistically signiﬁcant interaction
as observed between depressive symptoms and homelessness
homelessness <1 month: (p = 0.405); homelessness ≥1 month:
p = 0.466)] nor between sex with an IDU partner and homelessness
homelessness <1 month: (p = 0.596); homelessness ≥1 month:
p = 0.065)]. This data is not shown.
.3.  Homelessness and injection-related risk behavior
Among consecutive visits when participants reported injec-
ion drug use, homelessness of any duration was  associated with
ubsequent injection-related risk behavior in unadjusted analysis
Table 5). In adjusted analysis, homelessness <1 month was  no
onger associated with subsequent injection-related risk behav-
or [AOR = 0.80, 95% CI (0.53, 1.21)] but homelessness ≥1 month
emained signiﬁcantly associated with subsequent injection-
elated risk behavior [AOR = 1.61, 95% CI (1.06, 2.45)]. Past history
f homelessness, non-black race, and previous needle and cotton
haring were signiﬁcantly associated with subsequent injection-
elated risk behavior. The association between sex with an IDU
artner and subsequent injection-related risk behavior was of bor-
erline statistical signiﬁcance..  Discussion
We  observed a high frequency of homelessness in this sam-
le of current and former IDUs. Of particular concern was thater.
half  of the participants who reported any episode of homelessness
experienced recurrent homelessness. The relationship between
homelessness and subsequent injection drug use differed among
those who were actively injecting as compared to those who
were not. Homelessness was  associated with relapse among those
who had stopped injecting, but was not associated with sustained
injection drug use among active injectors. While homelessness
did not appear to inﬂuence sustained injection among active
injectors, it was  associated with increased likelihood of injection-
related risk behavior among those who were homeless for at least
1 month.
These study ﬁndings are consistent with other studies that
demonstrate frequent homelessness among IDUs, and studies that
have shown a temporal relationship between homelessness and
relapse (Mehta et al., 2012; Shah et al., 2006). Our ﬁndings are
also comparable to studies that have demonstrated an association
between incarceration and relapse (Mehta et al., 2012), and hav-
ing a drug using partner and relapse (Termorshuizen et al., 2005).
Further, the ﬁndings from this study demonstrate an inverse asso-
ciation between HIV positivity and sustained injection drug use as
seen previously (Celentano et al., 1994).
Our study did not demonstrate that homelessness among active
injectors increased or decreased the likelihood of sustained injec-
tion drug use after adjusting for other factors. This may  reﬂect the
baseline level of instability among active injectors such that home-
lessness has little additional inﬂuence on whether one continues
or stops injecting. However, the relationship between homeless-
ness and subsequent injection-related risk behavior among active
injectors raises concerns. While HIV seroconversion in this cohort
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Table  3
Unadjusted and adjusted association between homelessness and relapse among 994 participants who  reported no previous injection drug use across 3983 visits from 2005
to  2009 (Model 2).
Unadjusted OR 95% CI Adjusted ORa 95% CI
Homelessness
No homelessness Ref Ref
<1  Month 2.03 1.23, 3.35 1.67 1.01, 2.74
≥1  Month 1.74 0.99, 3.05 1.34 0.77, 2.33
Past  history of homelessness 1.23 0.86, 1.75 1.05 0.74, 1.49
Demographic
Ages  (years)
19–34 Ref Ref
35–54  0.65 0.26, 1.63 0.73 0.29, 1.86
55+  0.34 0.13, 0.90 0.42 0.16, 1.12
Female  1.02 0.72, 1.45 0.78 0.56, 1.10
Black  0.94 0.47, 1.87 1.38 0.70, 2.73
Legal  income ≥$5000 USD 0.55 0.40, 0.75 0.64 0.46, 0.88
Current  employment 0.77 0.56, 1.05 0.98 0.71, 1.34
Mental  health
Depressive symptoms 1.99 1.43, 2.77 1.79 1.29, 2.49
Depressionb 1.54 1.12, 2.12
Manic  depressionb 1.29 0.86, 1.94
Anxietyb 1.30 0.87, 1.95
Schizophreniab 1.13 0.76, 1.69
Suicidal  thoughts 1.36 0.83, 2.24
Suicide  plans 1.00 0.46, 2.17
Suicide  attempts 2.16 0.59, 7.99
HIV
HIV  positive 1.18 0.82, 1.70 1.06 0.75, 1.50
Risk  behavior
Incarcerated 2.13 1.38, 3.29 1.91 1.24, 2.94
Sex  with an IDU partner 1.56 1.09, 2.23 1.57 1.09, 2.27
Trade  sex for drugs, money, food, or shelter 0.96 0.83, 1.11 0.92 0.79, 1.08
Crack  use 1.60 1.13, 2.25 1.32 0.94, 1.86
Methadone  maintenance 1.27 0.91, 1.80 1.36 0.97, 1.90
Detoxiﬁcation  1.41 0.70, 2.82 1.41 0.71, 2.78
Note: All factors are time-varying excluding age, gender, and race, which are measured at the ﬁrst visit. All time-varying factors are measured within the last 6 months,
excluding current employment measured at the time of the visit, and depressive symptoms measured in the past week. Time-varying factors are lagged one visit from
when injection drug use is measured. Previous injection drug use refers to injection drug use measured at the lagged visit. Past homelessness is deﬁned as any episode of
homelessness prior to when homelessness is measured.
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as declined over recent years (Mehta et al., 2006) HCV incidence
emains high (Mehta et al., 2011), partly due to the large reservoir
f HCV among IDUs and the greater likelihood of HCV transmission
as compared to HIV) through a single exposure (Sulkowski et al.,
002). Among persons recruited to ALIVE during the 2005–2008
ave, HCV incidence in the ﬁrst year after recruitment was 7.8
er 100 per year compared with 0 for HIV (Mehta et al., 2011).
 recent study demonstrated an association between HCV inci-
ence and unstable housing among IDUs (Kim et al., 2009) and
his association may  partially be mediated by paraphernalia shar-
ng.
This study has limitations that may  impact the interpreta-
ion of results. Because we were unable to determine the exact
ime of exposure, we could not ascertain whether homelessness
receded or followed episodes of mental illness, or the occur-
ence of other events, which may  be associated with subsequent
njection drug use. Additionally, our deﬁnition of homelessness
id not consider the different types of locations where partici-
ants slept, due to sample size. This may  partially explain the
bserved differences in the magnitude and statistical signiﬁcance
f the associations between duration of homelessness and injec-
ion drug use, and injection-related risk behavior. Studies have
emonstrated that patterns of drug use vary across settings. For
xample, temporary housing (e.g., hostels) has been described as
eing conducive to injection drug use and risky behavior (Briggs
t al., 2009; Wright et al., 2005). Further, even though they may
ot prevent residents from using drugs or engaging in risky behav-
ors off premises (Gibson et al., 2011), shelters that require sobrietyer.
and  administer drug testing may  prevent residents from using
drugs. It has also been reported that homeless drug users tend to
reduce the amount of drugs that they use due to lack of income
(Wright et al., 2005). But, at the same time, lack of income may
actually encourage injection-related risk behavior among home-
less IDUs who spend signiﬁcant time on the street (Bourgois,
1998).
In this study, sleeping in a shelter or on the streets was reported
more frequently when homelessness ≥1 month was reported as
compared to when homelessness <1 month was reported. The
lower likelihood of injection drug use among persons homelessness
≥1 month (as compared to <1 month) in this study may reﬂect fac-
tors present in shelters, and on the streets, which may  discourage
injection drug use. Further, lack of income among homeless persons
on the streets may  reduce the quantity of drugs used (Wright et al.,
2005), but increase the likelihood of injection-related risk behavior
(Bourgois, 1998). This may  explain the association between home-
lessness ≥1 month and injection-related risk behavior observed
in this study, as sleeping on the streets was frequently reported
by participants homeless for ≥1 month. Additional research on
the impact that different settings have on injection drug use is
needed.
Other limitations include the exclusion of visits due to missing
information and gaps between visits, which can induce selection
bias. Previous homelessness, HIV positivity, depressive symptoms,
incarceration, not having an IDU sex partner, legal income less
than $5000 USD, and unemployment were observed more fre-
quently (≥10%) among visits excluded due to missing information
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Table  4
Unadjusted and adjusted association between homelessness and sustained injection drug use among 992 participants who  reported previous injection drug use across 2677
visits  from 2005 to 2009 (Model 3).
Unadjusted OR 95%  CI Adjusted ORa 95% CI
Homelessness
No homelessness Ref Ref
<1  Month 1.43 1.01, 2.04 1.03 0.71, 1.49
≥1  Month 1.25 0.89, 1.77 0.81 0.56, 1.17
Past  history of homelessness 0.98 0.74, 1.31 1.02 0.76, 1.37
Demographic
Ages  (years)
19–34 Ref Ref
35–54  0.54 0.32, 0.91 0.81 0.46, 1.44
55+  0.46 0.25, 0.85 0.65 0.34, 1.27
Female  0.60 0.45, 0.81 0.52 0.38, 0.71
Black  0.46 0.31, 0.70 0.66 0.41, 1.06
Legal  income ≥$5000 USD 0.82  0.61, 1.10 0.86 0.63, 1.17
Current  employment 1.06 0.77, 1.46 1.10 0.79, 1.54
Mental  health
Depressive symptoms 1.69 1.29, 2.22 1.58 1.19, 2.10
Depressionb 0.80 0.61, 1.04
Manic  depressionb 0.90 0.65, 1.28
Anxietyb 0.92 0.65, 1.31
Schizophreniab 0.94 0.67, 1.31
Suicidal  thoughts 1.05 0.76, 1.44
Suicide  plans 1.29 0.79, 2.09
Suicide  attempts 1.28 0.59, 2.78
HIV
HIV positive 0.52 0.38, 0.71 0.57 0.41, 0.78
Risk  behavior
Frequency of Injection
Less  than daily Ref Ref
Daily  2.13 1.70, 2.67 1.83 1.44, 2.31
Needle  sharing 1.77 1.35, 2.33 1.02 0.72, 1.43
Cotton  sharing 2.36 1.78, 3.14 1.98 1.42, 2.76
Shooting  gallery attendance 1.25 0.83, 1.88 0.72 0.46, 1.13
Incarcerated  1.31 0.97, 1.77 1.06 0.78, 1.45
Sex  with an IDU 1.31 1.01, 1.70 1.18 0.87, 1.61
Trade  sex for drugs, money, food, or shelter 1.03 0.91, 1.18 0.95 0.82, 1.11
Crack  use 1.18 0.93, 1.50 1.06 0.82, 1.36
Methadone  maintenance 0.70 0.52, 0.93 0.83 0.61, 1.11
Detoxiﬁcation  0.92 0.64, 1.31 0.72 0.49, 1.04
Overdose
Non-fatal  overdose 1.68 1.19, 2.37 1.35 0.94, 1.93
Note: All factors are time-varying excluding age, gender, and race, which are measured at the ﬁrst visit. All time-varying factors are measured within the last 6 months,
excluding current employment measured at the time of the visit, and depressive symptoms measured in the past week. Time-varying factors are lagged one visit from
when injection drug use is measured. Previous injection drug use refers to injection drug use measured at the lagged visit. Past homelessness is deﬁned as any episode of
homelessness prior to when homelessness is measured.
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b Self-reported diagnosis or treatment for mental health illness by a health care p
ompared to visits that were included. Previous injection drug
se, homelessness, HIV positivity, incarceration, sex with an IDU
artner, legal income less than $5000 USD, unemployment, daily
njection and cotton sharing were reported with greater frequency
cross visits excluded due to gaps as compared to visits included
n analysis. Because only 6% of visits were excluded due to miss-
ng information or gaps between visits, it is expected that these
xclusions did not overly impact our ﬁndings.
Finally, ALIVE represents a community-based cohort of pre-
ominantly middle-aged black men. Therefore these ﬁndings may
ot be generalizable to all IDUs. However these demographics are
onsistent with what has been reported in Baltimore by other
ources.
With mounting evidence demonstrating a temporal relationship
etween homelessness, injection drug use, and injection-related
isk behavior, greater support for housing-based interventions for
ersons with a history of drug use is warranted. Persons with a
istory of drug use face challenges in acquiring and maintaining
roper housing, as they may  be more likely to be low-income,
nemployed, and have an incarceration record that can render
hem ineligible for subsidized housing. Housing First interventions,er.
which  provide housing to individuals without drug treatment or
engagement in other services as a prerequisite, have been shown to
increase housing stability and drug treatment retention among per-
sons with substance abuse and psychiatric disorders (Appel et al.,
2012; Tsemberis et al., 2004). Housing First models have also been
reported to lessen healthcare and societal costs (Larimer et al.,
2009).
This study suggests that homelessness is associated with relapse
into injection drug use among those who have stopped inject-
ing, and injection-related risk behavior among active injectors.
Together such mechanisms may partially explain the link between
homelessness and adverse outcomes including those related to
HIV and HCV. This study strengthens support for policies that
invest in affordable housing and Housing First models of care.
Additionally, this study highlights the importance of strengthen-
ing risk reduction services for unstably housed persons that cannot
abstain from injection. Greater understanding of the inﬂuence of
homelessness on addiction over time, and how policies and pub-
lic health interventions can be tailored to prevent homelessness,
has the potential to improve drug recovery and other health out-
comes.
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Table  5
Unadjusted and adjusted association between homelessness and subsequent injection-related risk behavior among 689 participants consecutively reporting injection drug
use  across 1900 visits from 2005 to 2009 (Model 4).
Unadjusted OR 95% CI Adjusteda OR 95% CI
Homelessness
No homelessness (reference) Ref Ref
<1  Month 1.70 1.04, 2.78 0.80 0.53, 1.21
≥1  Month 4.22 2.54, 7.03 1.61 1.06, 2.45
Past  history of homelessness 1.09 0.72, 1.65 1.57 1.14, 2.17
Demographic
Ages  (years)
19–34 (reference) Ref Ref
35–54  0.33 0.15, 0.71 0.99 0.54, 1.79
55+  0.22 0.08, 0.58 0.99 0.49, 2.04
Female  1.42 0.80, 2.51 1.04 0.74, 1.47
Black  0.15 0.08, 0.32 0.54 0.33, 0.88
Legal  income ≥$5000 USD 0.92  0.58, 1.46 0.88 0.61, 1.28
Current  employment 0.91 0.56, 1.46 1.06 0.72, 1.57
Mental  health
Depressive symptoms 2.12 1.45, 3.10 1.22 0.90, 1.66
Depressionb 1.74 1.14, 2.67
Manic  depressionb 1.99 1.15, 3.47
Anxietyb 02.14 1.24, 3.69
Schizophreniab 01.69 0.98, 2.90
Suicidal  thoughts 11.66 1.04, 2.67
Suicide  plans 22.31 1.16, 4.63
Suicide  attempts 22.59 0.85, 7.96
HIV
HIV  positive 0.99 0.53, 1.85 1.21 0.84, 1.74
Risk  behavior
Frequency of injection
Less  than daily Ref Ref
Daily  injection 1.45 1.04, 2.03 1.18 0.90, 1.56
Needle  sharing 7.58 5.51, 10.41 3.58 2.57, 4.99
Cotton  sharing 5.66 4.11, 7.80 3.23 2.34, 4.44
Shooting  gallery attendance 4.10 2.33, 7.23 1.55 0.95, 2.53
Incarceration  1.50 0.98, 2.29 1.11 0.79, 1.58
Sex  with an IDU 2.79 1.90, 4.11 1.41 0.99, 1.99
Trade  sex for drugs, money, food, or shelter 1.09 0.88, 1.34 0.92 0.77, 1.10
Crack  use 1.95 1.34, 2.84 1.22 0.91, 1.63
Methadone  maintenance 1.10 0.69, 1.73 0.98 0.70, 1.39
Detoxiﬁcation  0.97 0.59, 1.59 0.79 0.51, 1.20
Overdose
Non-fatal  overdose 2.14 1.37, 3.34 1.00 0.68, 1.46
Note: All factors are time-varying excluding age, gender, and race, which are measured at the ﬁrst visit. All time-varying factors are measured within the last 6 months,
excluding current employment measured at the time of the visit, and depressive symptoms measured in the past week. Time-varying factors are lagged one visit from when
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